Advertisement

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy

HER2+ Breast Cancer: Brain Metastasis Prevalence & Later-Line Therapy Erika P. Hamilton, MD, provides an overview of HER2+ metastatic breast cancer management, especially in patients with brain metastases, and discusses the treatment of patients past frontline.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,

Post a Comment

0 Comments